O2-10-1A phase II study of first-line low-dose afatinib in patients with EGFR mutated non-small-cell lung cancer (KTORG1402)
Takehiro Okuno,Toshihide Yokoyama,Hiroshige Yoshioka,Daichi Fujimoto,Katsuya Hirano,Takahiro Kawai,Ryogo Kagami,Tadashi Ishida,Keisuke Tomii,Yoshiki Demura,Masataka Hirabayashi,Takashi Nishimura,Yasuharu Nakahara,Young Hak Kim, Kenichi Yoshimura,Toyohiro Hirai Annals of Oncology（2018）
AI 理解论文
溯源树
样例
